Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,705 public trials 3,134 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

NCT03969329

Conditions
Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Fakultni nemocnice v Motole Prague, Czechia
  • Hospices Civils de Lyon Hopital Femme Mere Enfant Bron, France
  • Hopital Armand Trousseau Paris, France
View all 23 locations
View Trial Details
Recruiting

Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader

NCT05294731

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Chao Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
View all 29 locations
View Trial Details
Recruiting

ED Medicaid Support

NCT07594782

Conditions
Disease Attributes, Emergencies, Pathologic Processes, +2 more
Locations
  • Hackensack Univarsity medical Center Hackensack, New Jersey, United States
View Trial Details
Recruiting

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

NCT07297979

Conditions
Disease Attributes, Ewing Sarcoma, Neoplasms, +10 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

NCT04590326

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +25 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 28 locations
View Trial Details

Related conditions